Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07316166
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing elective total hip arthroplasty
* 18-80 years old
* ASA 1-3 classifications
Exclusion Criteria:
* ASA classification of 4 or greater
* Infection at the site of nerve blockade
* Coagulopathy
* Known allergy to study medications
* Chronic opioid consumption (\>3 months)
* Currently using lidocaine patches
* Pre-existing neuropathy
* A history of CVA
* High grade atrioventricular block (cardiac conduction system impairment)
* Organ dysfunction (cardiac failure, respiratory failure, end stage renal disease, hepatic dysfunction, hypoalbuminemia)
* Morbid obesity (≥40 kg/m2)
* Prior surgery in supra and/or infrainguinal region
* Non-English-speaking participants
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07316166
Study Brief:
Protocol Section:
NCT07316166